Verition Fund Management LLC Infla Rx N.V. Transaction History

Verition Fund Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.25 - $3.03 $192,962 - $259,855	-85,761 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.72 - $4.04 $84,140 - $124,973	-30,934 Reduced 26.51%	85,761 $255,000
Q1 2021 May 18, 2021	BUY	$3.62 - $6.34 $60,435 - $105,846	16,695 Added 16.7%	116,695 $455,000
Q4 2020 Feb 16, 2021	BUY	$3.82 - $5.32 $38,200 - $53,200	10,000 Added 11.11%	100,000 $503,000
Q3 2020 Nov 16, 2020	SELL	$3.7 - $5.47 $18,500 - $27,350	-5,000 Reduced 5.26%	90,000 $383,000
Q2 2020 Aug 14, 2020	BUY	$4.59 - $8.96 $436,050 - $851,200	95,000 New	95,000 $436,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $103M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.